U.S. Communications Stock News

Event context and recent stock performance Upstream Bio (UPB) has drawn investor attention after a sharp move in its share price, with the stock down about 13% on the day and weaker over the past week and month. Those short term moves come against a stronger past year, where total return sits around 75%. This raises questions about how investors are weighing the company’s clinical stage respiratory pipeline in relation to its financial profile and recent trading volatility. See our latest...

If you are wondering whether Skyward Specialty Insurance Group is attractively priced at its current level, this article will walk through what the recent numbers might be telling you about value. The share price recently closed at US$46.61, with returns of 6.4% over the last 7 days, 1.1% over the last 30 days, and year to date and 1 year returns of a 4.1% decline and a 4.4% decline, alongside a very large 3 year return of around 2x. Recent headlines around Skyward Specialty Insurance Group...

What is moving A. O. Smith (AOS) now? A. O. Smith (AOS) has attracted fresh attention after a solid recent run, with the share price up around 13% over the past month and about 21% in the past 3 months. See our latest analysis for A. O. Smith. That short term strength backs up a steady record, with a 17.42% year to date share price return and a 25.46% 1 year total shareholder return suggesting momentum has been building rather than fading. If A. O. Smith’s recent run has you thinking about...

Papa John's International is running a MICHELIN Star themed campaign that includes turning a Manhattan store into a one night, reservation only dining experience. The company is also introducing a limited time heart shaped pizza in Canada for Valentine’s Day. These marketing and product moves aim to create buzz around the brand and offer differentiated experiences to pizza customers. Papa John's International, listed on NasdaqGS:PZZA, is pursuing attention grabbing brand efforts at a time...

Equity LifeStyle Properties (ELS) has declared a first quarter 2026 dividend of $0.5425 per common share, equivalent to $2.17 on an annualized basis, with payment scheduled for April 10 to shareholders of record on March 27. See our latest analysis for Equity LifeStyle Properties. At a share price of US$65.95, Equity LifeStyle Properties has seen a 10.30% year to date share price return and a 21.11% total shareholder return over five years. The recent dividend update helps frame current...

If you have been wondering whether Morningstar's share price now lines up with its underlying worth, this article is designed to walk you through that question clearly and calmly. The stock last closed at US$155.35, with returns showing a 13.9% decline over 7 days, 28.9% decline over 30 days, 26.2% decline year to date, 51.1% decline over 1 year, 33.8% decline over 3 years and 36.3% decline over 5 years. These moves have arrived alongside ongoing investor interest in how Morningstar's...

Pacira BioSciences (NASDAQ:PCRX) has had a rough three months with its share price down 8.6%. It seems that the market...

JM Group (JMG) has put fresh numbers on the table for FY 2025, with second half revenue of HK$122.0 million and basic EPS of HK$0.39, while the trailing twelve months show revenue of HK$269.4 million and EPS of HK$1.17 backed by net income of HK$18.7 million. The company has seen revenue move from HK$92.1 million and EPS of HK$0.12 in 2H 2024 to HK$147.3 million and EPS of HK$0.78 in 1H 2025, before landing at the latest half year figures. Over the past year, earnings growth of 165.4% has...

If you are wondering whether American Water Works Company is fairly priced or not, this article will walk you through what its current share price might be implying about value. The stock recently closed at US$123.69, with returns of a 0.5% decline over 7 days, a 5.1% decline over 30 days, a 5.1% decline year to date, a 1.4% gain over 1 year, an 11.2% decline over 3 years and a 14.9% decline over 5 years. Recent moves in the share price have kept investor attention on how a regulated water...

The Sprinklr, Inc. ( NYSE:CXM ) share price has fared very poorly over the last month, falling by a substantial 25...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

In early February 2026, Voyager Technologies secured its sixth patent for the Bishop Airlock’s electrical power and data-interface architecture, deepening protection around its modular space-station infrastructure, while also adding a new NASA Johnson Space Center IDIQ mission management contract worth up to US$24.50 million over four years and breaking ground on a 150,000 sq ft defense manufacturing complex in Pueblo, Colorado. Together with a new partnership with Max Space on expandable...

Old Second Bancorp (NasdaqGS:OSBC) has authorized a new share repurchase program of up to $43.9 million. The buyback authorization extends through 2026. The program adds another capital return tool alongside existing balance sheet and lending activities. Old Second Bancorp, the holding company for Old Second National Bank, operates as a regional banking provider focused on lending, deposits, and other financial services. For investors, a new repurchase authorization of this size can be an...

Scorpio Tankers Inc. ( NYSE:STNG ) shares have had a really impressive month, gaining 27% after a shaky period...

The market seemed underwhelmed by the solid earnings posted by Embecta Corp. ( NASDAQ:EMBC ) recently. We have done...

If you are wondering whether KBR's current share price lines up with its underlying worth, you are not alone and this article is here to help you size up that question quickly. KBR closed at US$40.90, with returns of 4.1% decline over 7 days, 7.7% decline over 30 days, a 1.0% gain year to date, and a 22.2% decline over 1 year, while the 5 year return sits at 36.7% and the 3 year return at 18.4% decline. Recent coverage around KBR has focused on its position in the commercial services space...

Klaviyo (KVYO) has capped FY 2025 with Q4 revenue of US$350.2 million and basic EPS of US$0.02, while on a trailing twelve month basis the business generated US$1.2 billion of revenue and a net loss of US$31.8 million. The company has seen quarterly revenue move from US$270.2 million in Q4 FY 2024 to US$350.2 million in Q4 FY 2025, and basic EPS shift from a loss of US$0.10 to a small profit of US$0.02 over the same period. This sets up an earnings season story that hinges on how durable this...

If you are looking at First Merchants and wondering whether the current share price still represents good value, you are not alone. The stock last closed at US$42.05, with returns of 0.5% over the past 7 days, 11.7% over 30 days, 12.1% year to date and a 1% decline over the past year, which may signal changing expectations around its prospects and risk. This article was prompted by Simply Wall St's evergreen coverage of First Merchants, which periodically refreshes to keep valuation and...

MNTN (MNTN) has put a cleaner set of numbers on the table for FY 2025 so far, with Q3 revenue of US$70.0 million and basic EPS of US$0.09 off net income of US$6.4 million, against a trailing twelve month backdrop that still shows a loss of US$44.9 million on revenue of US$272.8 million and EPS of US$1.25. The company has seen quarterly revenue move from US$54.8 million in Q2 2024 to US$70.0 million in Q3 2025. EPS has swung across losses of US$0.69, US$1.41 and US$0.65 in early FY 2025 before...

Key Insights Boston Beer Company's estimated fair value is US$329 based on 2 Stage Free Cash Flow to Equity Boston Beer...

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

Liberty Energy Inc. ( NYSE:LBRT ) shares have continued their recent momentum with a 27% gain in the last month alone...

Edwards Lifesciences FY 2025 earnings snapshot Edwards Lifesciences (EW) has wrapped up FY 2025 with fourth quarter revenue of US$1,569.6 million and basic EPS of US$0.11, setting the tone for how investors assess the latest stretch of results. The company has seen revenue move from US$1,385.8 million in Q4 2024 to US$1,569.6 million in Q4 2025, while basic EPS over that same period went from US$0.59 to US$0.11. This puts the focus squarely on how efficiently those sales are translating into...

Quest Diagnostics (NYSE:DGX) has introduced a blood based minimal residual disease test for multiple myeloma that uses advanced flow cytometry. The company reports that the assay offers sensitivity comparable to next generation sequencing with a lower expected cost and less invasive sampling. FDA draft guidance recognizes minimal residual disease as an endpoint in multiple myeloma clinical trials, supporting broader use of MRD testing in research. For you as an investor, this development...